CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.26B, above the global median of $1.18B
- FinancialsAltman Z-Score 5.96: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.17%Below 5Y avg (2.50%)
Annual Rate
CNY 0.10Paid annual
Payout Ratio
77.8%Moderate
Payback Period
86.4 yr
Last Ex-Dividend
Sep 16, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.46BCNY1.26B · vs all stocks (USD)
Trailing P/E
21.92xRevenue (TTM)
3.85BCNY574.02M · vs all stocks (USD)
Profit Margin
10.03%Beta
0.1840xvs all stocks
52-Week Change
-13.55%vs all stocks
Market Capitalization
8.46BCNY1.26B · vs all stocks (USD)
Enterprise Value
7.34BCNY1.09B · vs all stocks (USD)
Trailing P/E
21.92xForward P/E
10.06xPrice to Sales (TTM)
2.20xPrice to Book (MRQ)
1.39xEnterprise to Revenue
1.91xEnterprise to EBITDA
11.38xGross Margin
64.52%Profit Margin
10.03%Operating Margin
18.88%Return on Assets (TTM)
3.78%Return on Equity (TTM)
6.66%Revenue (TTM)
3.85BCNY574.02M · vs all stocks (USD)
Revenue per Share (TTM)
3.85CNYUpdated Sep 19, 2026Quarterly Revenue Growth
20.80%Gross Profit (TTM)
2.30BCNY343.70M · vs all stocks (USD)
EBITDA (TTM)
589.92MCNY87.99M · vs all stocks (USD)
Net Income (TTM)
385.93MCNY57.56M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-8.30%Operating Cash Flow (TTM)
607.62MCNY90.63M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
362.75MCNY54.11M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1000CNYUpdated Sep 19, 2026Trailing Annual Dividend Yield
1.17%vs all stocks
5-Year Average Dividend Yield
2.50%vs all stocks
Payout Ratio
77.80%Minority Interest (Equity)
46.98MCNYFY2025 · Dec 31, 2025Revenue
3.76BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.46BCNYFY2025 · Dec 31, 2025Gross Profit
2.30BCNYFY2025 · Dec 31, 2025Operating Income
490.12MCNY73.11M · vs all stocks (USD)
Pre-tax Income
535.84MCNYFY2025 · Dec 31, 2025Income Tax Expense
83.24MCNYFY2025 · Dec 31, 2025Net Income
452.60MCNYFY2025 · Dec 31, 2025EBIT
540.49MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
762.25MCNYFY2025 · Dec 31, 2025Research & Development
303.75MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.11BCNYFY2025 · Dec 31, 2025Other Operating Expenses
39.50MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
16.73MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
4.64MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4500CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4500CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
999.20MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
999.20MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
452.60MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-2.96MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
175.93MCNYFY2025 · Dec 31, 2025Free Cash Flow
-32.38MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.19BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
452.60MCNYFY2025 · Dec 31, 2025Other Non-cash Items
10.42MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-275.98MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-11.11MCNYFY2025 · Dec 31, 2025Capital Expenditures
-208.31MCNYFY2025 · Dec 31, 2025Net Acquisitions
10.46MCNYFY2025 · Dec 31, 2025Purchase of Investments
-500.00KCNYFY2025 · Dec 31, 2025Sale of Investments
2.21MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-196.14MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
414.95MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-270.94MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-401.51MCNYFY2025 · Dec 31, 2025Other Financing Charges
-3.70MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-261.21MCNYFY2025 · Dec 31, 2025Shares Outstanding
989.20MSharesUpdated Sep 19, 2026Float Shares
753.38MSharesUpdated Sep 19, 2026% Held by Insiders
26.69%vs all stocks
% Held by Institutions
6.12%vs all stocks
Total Cash (MRQ)
1.17BCNY174.15M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.20CNYUpdated Sep 19, 2026Total Debt (MRQ)
157.94MCNY23.56M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0263xCurrent Ratio (MRQ)
3.67xBook Value per Share (MRQ)
6.14CNYUpdated Sep 19, 2026Total Assets
7.26BCNY1.08B · vs all stocks (USD)
Total Current Assets
3.30BCNYFY2025 · Dec 31, 2025Total Liabilities
1.18BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.96BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
127.77MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.05BCNYFY2025 · Dec 31, 2025Cash
1.19BCNYFY2025 · Dec 31, 2025Cash Equivalents
4.84MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.20BCNYFY2025 · Dec 31, 2025Accounts Receivable
525.99MCNYFY2025 · Dec 31, 2025Inventory
914.38MCNYFY2025 · Dec 31, 2025Accounts Payable
303.72MCNYFY2025 · Dec 31, 2025Short-term Debt
187.18MCNYFY2025 · Dec 31, 2025Other Current Liabilities
137.83MCNYFY2025 · Dec 31, 2025Long-term Debt
14.23MCNYFY2025 · Dec 31, 2025Common Stock (Book)
989.20MCNYFY2025 · Dec 31, 2025Retained Earnings
2.65BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
6.08BCNY907.20M · vs all stocks (USD)
52-Week Low
7.92CNYUpdated Sep 19, 202652-Week High
10.10CNYUpdated Sep 19, 202652-Week Change
-13.55%vs all stocks
Beta
0.1840xvs all stocks
50-Day MA
8.57CNYUpdated Sep 19, 2026200-Day MA
8.82CNYUpdated Sep 19, 2026Avg 10-Day Volume
9.48MSharesUpdated Sep 19, 2026Avg 30-Day Volume
13.68MSharesUpdated Sep 19, 2026Diluted EPS (TTM)
0.3900CNYUpdated Sep 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.96: safe zoneNotable
Altman Z-Score: 5.96
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.26B, above the global median of $1.18BNotable
Market cap (USD): 1,261,550,771.253Global Median: 1,180,223,658.953
Revenue is $574.02M, above the global median of $548.88MNotable
Revenue (USD): 574,023,697.336Global Median: 548,883,780.48
Levered free cash flow is $54.11M, above the global median of $18.73MNotable
Levered free cash flow (USD): 54,107,138.469Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Changzhou Qianhong Biopharma Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Integra LifeSciences Holdings Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Bicara Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Immatics N.V.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Celltrion Pharm, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Yahong Meditech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Damora Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Akums Drugs & Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Sun-Novo Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Yizhong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule